Nab-Paclitaxel in Combination With Carboplatin as First-line Therapy in Patients With NSCLC

NCT02799862 · clinicaltrials.gov ↗

COMPLETED

Status

408

Enrollment

INDUSTRY

Sponsor class

Conditions

Carcinoma, Non-Small-Cell Lung

Interventions

DRUG: Nab-Paclitaxel
DRUG: Carboplatin

Sponsor

iOMEDICO AG

Collaborators

[object Object]